Ramon Hartage
Columbus, OHNPI 1033640016
Payments from drug & device makers
$1,646in general payments, 2019–2025
Across 62 payments — averaging $26.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$384
- Genentech USA, Inc.$168
- Merck$167
- Incyte Corporation$153
- Novartis$85
- Syndax Pharmaceuticals, Inc.$73
- plus $615 from 16 others
What the payments were for
- Food & beverage$1,646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $384 |
| Genentech USA, Inc. | 7 | $168 |
| Merck | 5 | $167 |
| Incyte Corporation | 7 | $153 |
| Novartis | 3 | $85 |
| Syndax Pharmaceuticals, Inc. | 3 | $73 |
| Legend Biotech USA Inc. | 2 | $73 |
| Genmab U.S., Inc. | 3 | $66 |
| AbbVie | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| AstraZeneca | 2 | $45 |
| Astellas Pharma US Inc | 1 | $32 |
| Gilead | 1 | $30 |
| ADC Therapeutics America, Inc. | 1 | $30 |
| Seagen Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Sanofi | 1 | $25 |
| Cerus Corporation | 1 | $23 |
| GSK | 1 | $23 |
| Bristol Myers Squibb | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.